Articles By Jack Cush, MD
Ustekinumab Effective in Adolescents with Psoriasis
Biologic and new drug development seldom targets children and adolescents. This study evaluated the efficacy and safety of ustekinumab in adolescents age 12 to 17 years with moderate-to-severe psoriasis,
Read Article
Secukinumab Wins in Psoriatic Arthritis
Mease and colleagues have published their results of a phase 3 trial of secukinumab (anti-IL-17A Mab) in 606 patients with psoriatic arthritis (PsA).
Read Article
TICOPA Study: Tight Control in Psoriatic Arthritis
Tight control in rheumatoid arthritis was introduced with the TICORA trial and validated in numerous treat-to-target studies since. Now the benefits of tight control in psoriatic arthritis (PsA) have been reported.
Read Article
Health Hazards of Fructose and Soda
The health consequences of fructose-containing sugars, sucrose and high fructose corn syrup, found in sugar-sweetened beverages and foods, may be numerous and include obesity, type 2 diabetes, gout and cardiovascular disease.
Read Article
ICD-10: Preparing for the Next Y2K
ICD-10 starts tomorrow, October 1st. Your Coding memory will have to increase 5-fold or more as we go from 16,000 to 68,000 new ICD-10 codes. How this will affect each of us remains to be seen. There’s a lot to learn, and many wonder if this will be the next “Y2K”.
Read Article
DSB: Drug Shortages - September 2015
RheumNow is committed to reporting safety issues in our monthly Drug Safety Bulletins. Each month we will update you with reports of new, ongoing and resolved Drug Shortages that will affect the practicing rheumatologist.
Read Article
High Sodium Intake Linked to Risk of RA
Diet has long been considered a potential risk factor for the onset or pathogenesis of rheumatoid arthris. Obesity and the microbiome are being intensively studied as risk factors for RA.
Read Article
Rheumatoid Arthritis Associated with More Severe Acute Coronary Syndromes and Outcomes
Acute coronary syndromes (ACSs), myocardial infarctions and heart failure appear to be a hazardous consequence to systemic and articular inflammation in rheumatoid arthritis.
Read Article
ACR/SPARTAN 2015 Recommendations for Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
The ACR and SPARTAN (Spondyloarthritis Research and Treatment Network) has worked together to study 57 specific treatment questions regarding AS and SpA. The following guidelines have recently been published after conducting systematic literature reviews.
Read Article
Dr. Woodcock Gives Senate FDA Update on Biosimilars
Biologics have been a great advance in therapeutics, but at great cost. Although biologics account for less than 1% of all prescriptions in the USA, they account for 28% percent of the cost of prescribed medications.
Read Article